Pacific Biosciences Of California reported $19.25M in Cost of Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Agilent A:US $ 764M 4M
Fluidigm FLDM:US $ 18.02M 3.19M
Myriad Genetics MYGN:US $ 45.8M 2M
Nanostring Technologies NSTG:US $ 88.35M 71.2M